Amit Singh

Partner and West Coast Corporate Lead

Dentons US LLP
4655 Executive Drive, Suite 700, San Diego, CA 92121

D +1 619 699 2541   |   M +1 858 922 7144
amit.singh@dentons.com
Bio   |   Website

ABOUT AMIT SINGH

Amit Singh is a Partner and West Coast Corporate Lead at Dentons US LLP, the world’s largest law firm.

Amit is highly skilled in business transactions. He focuses on venture capital and private equity transactions, mergers and acquisitions, joint ventures, technology transactions, and general corporate law for companies whose core value derives from intellectual property. In the hundreds of M&A, venture capital and other sophisticated business transactions he’s led over the last two decades and as outside general counsel to life sciences and technology companies, Amit has immersed himself in his clients’ businesses, providing practical legal advice in the context of the clients’ overall business goals.

He also represents managers and investors in the formation of venture capital, private equity and hedge funds. Amit has extensive experience counseling companies and investors in a broad range of industries, including life sciences, software, hardware, communications and networking, Internet, manufacturing and distribution, and medical devices.

Amit is a frequent speaker and author on startups, venture capital and M&A and has written hundreds of thought leadership articles on his blog – www.startupblog.com.

Amit earned an LL.M. (Corporate Law) from New York University School of Law in 1999 and a J.D. in 1998 from University of California, Hastings College of the Law.

He is a member of the State Bar of California and the State Bar of New York.

Amit Singh
Partner and West Coast Corporate Lead

Dentons US LLP
4655 Executive Drive, Suite 700, San Diego, CA 92121

D +1 619 699 2541   |   M +1 858 922 7144
amit.singh@dentons.com
Bio   |   Website

Recent Speaking Engagements, Publications & Interviews

  • Interviewed by Law360 – “Questions Linger Over Coinbase’s Potential Public Listing” about Coinbase’s potential direct public offering. (August 2020)

  • Featured speaker: PPP Loans : Practical Advice on Asking for Forgiveness & an Update on Recent Changes. (June 16, 2020)

  • Interviewed by the New York Times – “Wealth Advisers Torn Over Taking Small-Business Aid” about the Paycheck Protection Program and the ability of investment advisory firms to take related loans. (June 12, 2020)

  • Interviewed by Technology Transfer Tactics – “Equity Crowdfunding may be Tempting for University Start-ups as Investments dry up” about equity crowdfunding as an alternative to VC funding in the pandemic environment for startups spinning out of university technology transfer offices. (June 2020)

  • Panelist: “Deal Structuring,” Tech Coast Angels (May 2020)

  • Interviewed by BlockTelegraph regarding the SEC’s first ever loss in an ICO case. The article, “A Federal Judge Just Chin-checked the SEC. Here’s What It Means” covers the case in which a federal judge denied the SEC a preliminary injunction against Blockvest LLC after previously granting a temporary restraining order on the same issue.

  • “Capital Formation Deal Elusive as Senators Race Against Clock,” published by Bloomberg Law – Securities Law News on November 30. The article covered the bipartisan package of capital formation bills, also known as the Jobs Act 3.0, that passed the House in July and is trying to make its way to the Senate floor.

  • “ICO Mania Cools Amid Regulatory Crackdown, Crypto Plunge,” published by Law360 on November 30. The article covered the recent decline in ICO offerings and fundraising coinciding with increased regulatory scrutiny by the SEC, which penalized two issuers for unregistered ICOs earlier this month.

  • “Securities Attys Challenged By New Role As ICO Gatekeepers,” Law360 (May 2018). The article discussed how the SEC believes attorneys are meant to be “ICO gatekeepers” and should be held accountable for the advice they give to their clients in determining if their ICO should be registered with the SEC or not.

  • “Structuring Investments in Startup Companies,” Tech Coast Angels (May 2018)

  • “Should I tokenize? ICO vs. Crowdfunding,” Crypto Invest Summit (May 2018)

  • “Term Sheet and Structuring the Deal” panel, Tech Coast Angels: Angel Investing 101 Workshop (March 2017 and 2018)

  • “Regulation A+ Tier 2: Conducting a Mini IPO,” NIRI OC Crowdfunding event (January 2018)

  •  “Introduction to Initial Coin Offerings,” Stradling (January 2018)

  • “Corporate and Securities Roundtable: Drafting and Negotiating Effective Contracts Series: Advanced Issues in Contract Drafting: Avoiding the Pitfalls,” ACC San Diego (December 2017)

  • “Corporate and Securities Roundtable: Drafting and Negotiating Effective Contracts Series: Representations and Warranties and Indemnification: How they Work Together,” ACC San Diego (October 2017)

  • “Corporate and Securities Roundtable: Drafting and Negotiating Effective Contracts Series: Contract Provisions Related to Intellectual Property Rights,” ACC San Diego (September 2017)

  • “Legal Pitfalls in Equity Crowdfunding,” Crowd Invest Summit (2016 and 2017)

  • “Corporate and Securities Roundtable: Drafting and Negotiating Effective Contracts Series: Boilerplate – More Important Than You Might Think,” ACC San Diego (June 2017)

  • “Cap Tables and Cap Table Management,” Canopy San Diego (June 2017)

  • Judge, TiE Young Entrepreneurs Business Plan Competition (May 2017)

  • “Corporate and Securities Roundtable: Drafting Contracts in the Digital Age,” ACC San Diego (May 2017)

  • “Capital Track FrameWorks – Term Sheets” panel, CONNECT San Diego (April 2017)

  • “Term Sheet and Structuring the Deal” panel, Tech Coast Angels: Angel Investing 101 Workshop (March 2017)

  • “Regulation A+: Conducting a Mini IPO,” Orange County and San Diego Tech Coast Angels meeting (April 2016)

  • “Financing Trends in Cloud Computing: Venture Capital and M&A,” ACG OC SoCal Capital Summit (April 2016)

Representative Experience

  • Represented Thea as US counsel in its exclusive licensing agreement with Nevakar for the commercialization of a proprietary, investigational, preservative-free eye drop administered nightly and intended for slowing the progression of myopia in children.
  • Represented Merage Venture Fund in the Convertible Note Financing of a computational storage services company.
  • Represented Merage Venture Fund in the Series C Financing of an Israeli innovative food technology company.
  • Represented Merage Venture Fund and Kamran Siminou in the Series A Financing of an Israeli medical device company that is developing a breakthrough treatment for dry eye syndrome.
  • Represented Merage Venture Fund and Kamran Siminou as lead investors in the Series A Financing of an Israeli company focusing on digital therapeutics for mental disorders.
  • Represented the buyer in a buyout of a leading car wash company.
  • Represented a medical device company in entering a Development Agreement with a leading, publicly traded medical device manufacturer.
  • Represented Atlazo, Inc. in connection with its $11 million Series A Financing.

  • Represented a leading IoT company in connection with the acquisition of the fleet tracking business of a large public company.

  • Represented Primo Wind, a developer of alternative energy solutions, in a restructuring transaction and a related financing transaction.

  • Represented Positioning Universal Holdings Inc. in connection with its Series A Preferred Stock Offering and a related rights offering.

  • Represented Paul Merage and Kamran Siminou as lead investors in the $2 million Series A Preferred Stock Financing of Butterfly Medical Ltd., the developer of a unique implant for the treatment of aging men suffering from enlarged prostate (BPH) symptoms.

  • Represented Steelhead Composites, Inc., a manufacturer of lightweight, high-strength cylinders used for weight-sensitive energy and fuel storage applications, in connection with its restructuring and Series Seed Financing.

  • Represented Positioning Universal Holdings Inc. in connection with a three-way merger with Global Cloud Fleet Inc. and SVR Tracking Inc. and a related restructuring.

  • Represented Ifovea, Inc., an early stage medical device company, in connection with its Series Seed Financing.

  • Represented HMDmd, Inc., a developer of wearable, smart, medical grade displays, in connection with the negotiation of a License Agreement with a leading manufacturer of microdisplay solutions.

  • Ligand Invests in Dianomi Therapeutics

Represented Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) in connection with its $3 million investment in Dianomi Therapeutics, Inc., a biopharmaceutical company focused on improving the delivery and efficacy of large and small molecules in the treatment of a variety of diseases and on therapies for inflammatory diseases.

Represented DF Opco, LLC, a portfolio company of Stradling client Diversis Capital, LLC, in connection with its acquisition of Dari-Farms Ice Cream Co., Inc. (“Dari-Farms”).

Represented Diversis Capital in connection with an acquisition for its portfolio company, ArrowStream, Inc., of substantially all of the assets of American Restaurant Association, Inc. for equity in a newly formed subsidiary of ArrowStream, Inc.

Represented Ansun Biopharma, Inc. in connection with its $85 million Series A Financing round led by Sinopharm Healthcare Fund and Lilly Asia Ventures.

Represented Digital-Telepathy, Inc. in a transaction in which ServiceNow purchased Digital-Telepathy for an undisclosed purchase price. Digital-Telepathy will be integrated with ServiceNow’s design experience and product development teams.